Below are the most recent publications written about "Progesterone" by people in Profiles.
-
Boelig RC, Tersigni C, Di Simone N, Saccone G, Facchinetti F, Scambia G, Berghella V. Cerclage in singleton pregnancies with no prior spontaneous preterm birth and short cervix: a randomized controlled trial. Am J Obstet Gynecol MFM. 2025 Apr; 7(4):101602.
-
Williams CE, Boelig RC. Vaginal progesterone for prevention of preterm birth in women with a history of preterm birth regardless of cervical length: an argument for use. Am J Obstet Gynecol MFM. 2025 Mar; 7(1S):101565.
-
Wenner MM, Shenouda N, Shoemaker L, Kuczmarski A, Haigh K, Del Vecchio A, Schwab A, McGinty SJ, Edwards DG, Pohlig RT, Nuckols VR, DuBose L, Moreau KL. Characterizing vascular and hormonal changes in women across the life span: a cross-sectional analysis. Am J Physiol Heart Circ Physiol. 2024 Nov 01; 327(5):H1286-H1295.
-
Rana T, Gulersen M, Roman A, Boelig RC, Berghella V. Reply to Letter to Editor 'Vaginal progesterone should be offered to patients with a singleton gestation and a history of spontaneous preterm birth only if a cervical length =25 mm is detected at midtrimester'. Am J Obstet Gynecol MFM. 2024 01; 6(1):101216.
-
Berghella V, Gulersen M, Roman A, Boelig RC. Vaginal progesterone for the prevention of recurrent spontaneous preterm birth. Am J Obstet Gynecol MFM. 2023 10; 5(10):101116.
-
Hoffman MK, Clifton RG, Biggio JR, Saade GR, Ugwu LG, Longo M, Bousleiman SZ, Clark K, Grobman WA, Frey HA, Chauhan SP, Dugoff L, Manuck TA, Chien EK, Rouse DJ, Simhan HN, Esplin MS, Macones GA. Cervical Pessary for Prevention of Preterm Birth in Individuals With a Short Cervix: The TOPS Randomized Clinical Trial. JAMA. 2023 07 25; 330(4):340-348.
-
Boelig RC. Obstetric Indications for Progestin Therapy. Obstet Gynecol Clin North Am. 2023 Mar; 50(1):101-107.
-
Sgroi DC, Treuner K, Zhang Y, Piper T, Salunga R, Ahmed I, Doos L, Thornber S, Taylor KJ, Brachtel E, Pirrie S, Schnabel CA, Rea D, Bartlett JMS. Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study. Breast Cancer Res. 2022 12 16; 24(1):90.
-
Carlson EJ, Francis R, Liu Y, Li P, Lyon M, Santi CM, Hook DJ, Hawkinson JE, Georg GI. Discovery and Characterization of Multiple Classes of Human CatSper Blockers. ChemMedChem. 2022 08 03; 17(15):e202000499.
-
Boelig RC, Locci M, Saccone G, Gragnano E, Berghella V. Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2022 09; 4(5):100658.